Strengthening Surveillance, Diagnostics, and R&D Capacity for Emerging Infectious Diseases in Sub-Saharan Africa.

Stansile is inviting institutions, funders, academic groups, biotech companies, and regional/global health stakeholders to collaborate on a growing portfolio of emerging infectious diseases (EIDs) studies and R&D platforms across Central and East Africa. Our current work spans the Democratic Republic of the Congo, Rwanda, Burundi, Tanzania, and the broader African Great Lakes region, an epicenter for high-risk zoonotic spillover, rapid pathogen evolution, and recurrent outbreaks that require coordinated, innovative solutions.

Our Current and Ongoing Projects Include:

• The Genomic and Epidemiological Studies of Emerging and Re-emerging infectious Diseases (Mpox, Rift Valley Fever, Cholera, Malaria, etc): Multi-country genomic surveillance, serosurveys among high-risk groups, immune profiling, diagnostic validation, and longitudinal cohort follow-up of special populations, including pregnant women and infants.

• Observational Research on NCDs in HIV-Positive Populations: Through open and collaborative scientific partnerships, our longitudinal cohorts provide a robust platform to generate high-quality evidence on the evolving burden and management of non-communicable diseases among people living with HIV across diverse African settings. Our work aims to inform integrated, patient-centred care models that improve long-term health outcomes and quality of life for HIV-affected populations across the continent.

• Disease X Preparedness & Wastewater Surveillance: Protocol development and validation, multi-country sampling strategies, targeted and metagenomics analysis, and integration with public health decision-making.

• Artificial Intelligence & Digital Health Tools: AI-driven diagnostic tools development and validation using clinical imaging platforms, digital data-capture tools, mobile disease-screening applications, big data and machine learning and develop automated outbreak prediction models.

Areas for Collaboration

We welcome cooperation in the following domains:

• Joint research projects (clinical, epidemiological, genomic, immunological, One-Health)

• Diagnostic development & validation for point-of-care tools, syndromic panels, and next-generation sequencing workflows

• Technology transfer and local manufacturing of rapid tests, immunoassays, or mobile lab platforms

• Capacity building and next-generation workforce development (training, workshops, field sequencing, laboratory strengthening)

• Data science, AI/ML modelling, digital health systems, and analytics

• Biobanking, sample sharing frameworks, and multi-country field studies

• Co-design of grant proposals and consortium building under international funders and regional opportunities

Why Partner with Stansile?

• Strong multi-country presence across Central and East Africa with trusted collaborations with ministries of health, hospitals, academic institutions and research centres

• Proven capacity to execute complex field studies in outbreak and/or hard-to-reach settings

• Cutting-edge expertise in genomic surveillance, digital health ecosystems, and translational R&D

• Established biobanking and sample management infrastructure

• A highly agile and innovation-focused organization committed to equitable, sustainable scientific capacity

Call to Action

We invite partners who share our vision of accelerating research, strengthening diagnostics, and advancing preparedness for EIDs in Africa.

Stansile is open to co-designing projects, building long-term consortia, and creating impactful R&D pipelines that respond to regional and global health priorities.

For collaboration inquiries, please contact:

info@stansile.org